1-Benzyl-1,2,3,4-tetrahydroisoquinoline passes through the blood-brain barrier of rat brain: An in vivo microdialysis study

Neuroscience Letters

Volumn 395, Issue 1, 2006, Pages 63-66

  Song, Yaru ^a   Feng, Yangzheng ^b   LeBlanc, Michael H ^b   Castagloni Jr , Neal ^c   Liu, Yi Ming ^a  

^a JACKSON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

1 Benzyl 1,2,3,4 tetrahydroisoquinoline; Blood brain barrier; Liquid chromatography mass spectrometry; Neurotoxin; Tetrahydroisoquinoline

Indexed keywords

1 BENZYL 1,2,3,4 TETRAHYDROISOQUINOLINE; NEUROTOXIN; SALSOLINOL; TETRAHYDROISOQUINOLINE; TETRAHYDROISOQUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; DIALYSATE; DOSE RESPONSE; DRUG HALF LIFE; DRUG METABOLISM; EXTRACELLULAR FLUID; FRONTAL CORTEX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; MALE; MASS SPECTROMETRY; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; INJECTIONS, INTRAPERITONEAL; MALE; METABOLIC CLEARANCE RATE; MICRODIALYSIS; RATS; RATS, SPRAGUE-DAWLEY; TETRAHYDROISOQUINOLINES;

EID: 31744439810     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.10.050     Document Type: Article

References (19)

1. K. Abe, K. Taguchi, T. Wasai, J. Ren, I. Utsunomiya, T. Shinohara, T. Miyatake, and T. Sano Biochemical and pathological study of endogenous 1-benzyl-1,2,3,4-tetrahydroisoquinoline-induced parkinsonism in the mouse Brain Res. 907 2001 134 138
2. F. De Marco, M. Perluigi, M.L. Marcante, R. Coccia, C. Foppoli, C. Blarzino, and M.A. Rosei Cytotoxicity of dopamine-derived tetrahydroisoquinolines on melanoma cells Biochem. Pharmacol. 64 2002 1503 1512
3. H. Haber, A. Winkler, I. Putscher, P. Henklein, I. Baeger, M. Georgi, and M.F. Melzig Plasma and urine salsolinol in humans: effect of acute ethanol intake on the enantiomeric composition of salsolinol Alcohol. Clin. Exp. Res. 20 1996 87 92
4. R.E. Heikkila, A. Hess, and R.C. Duvoisin Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice Science 224 1984 1451 1453
5. K. Kikuchi, Y. Nagatsu, Y. Makino, T. Mashino, S. Ohta, and M. Hirobe Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds. 1,2,3,4-Tetrahydroisoquinoline and 1-methyl-1,2,3,4- tetrahydroisoquinoline Drug Metab. Dispos. 19 1991 257 262
6. Y. Kotake, S. Ohta, I. Kanazawa, and M. Sakurai Neurotoxicity of an endogenous brain amine, 1-benzyl-1,2,3,4-tetrahydroisoquinoline, in organotypic slice co-culture of mesencephalon and striatum Neuroscience 117 2003 63 70
7. Y. Kotake, Y. Tasaki, Y. Makino, S. Ohta, and M. Hirobe 1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF J. Neurochem. 65 1995 2633 2638
8. Y. Kotake, M. Yoshida, M. Ogawa, Y. Tasaki, M. Hirobe, and S. Ohta Chronic administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine in the brain, induces parkinsonism in a primate Neurosci. Lett. 217 1996 69 71
9. Y. Makino, S. Ohta, O. Tachikawa, and M. Hirobe Presence of tetrahydroisoquinoline and 1-methyl-tetrahydro-isoquinoline in foods: compounds related to Parkinson's disease Life Sci. 43 1988 373 378
10. T. Nagatsu Isoquinoline neurotoxins in the brain and Parkinson's disease Neurosci. Res. 29 1997 99 111
11. M. Naoi, W. Maruyama, Y. Akao, and H. Yi Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease Neurotoxicol. Teratol. 24 2002 579 591
12. M. Naoi, W. Maruyama, P. Dostert, and Y. Hashizume N-methyl-(R)salsolinol as a dopaminergic neurotoxin: from an animal model to an early marker of Parkinson's disease J. Neural. Transm. Suppl. 50 1997 89 105
13. T. Origitano, J. Hannigan, and M.A. Collins Rat brain salsolinol and blood-brain barrier Brain Res. 224 1981 446 451
14. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 1986 Academic Press Orlando
15. S. Shavali, and M. Ebadi 1-Benzyl-1,2,3,4-tetrahydroisoquinoline (1BnTIQ), an endogenous neurotoxin, induces dopaminergic cell death through apoptosis Neurotoxicology 24 2003 417 424
16. S. Shavali, J. Ren, and M. Ebadi Insulin-like growth factor-1 protects human dopaminergic SH-SY5Y cells from salsolinol-induced toxicity Neurosci. Lett. 340 2003 79 82
17. Y.J. Surh, Y.J. Jung, J.H. Jang, J.S. Lee, and H.R. Yoon Iron enhancement of oxidative DNA damage and neuronal cell death induced by salsolinol J. Toxicol. Environ. Health A 65 2002 473 488
18. A. Thumen, A. Behnecke, F. Qadri, E. Bauml, and A. Moser N-methyl-norsalsolinol, a putative dopaminergic neurotoxin, passes through the blood-brain barrier in vivo Neuroreport 13 2002 25 28
19. T. Yamakawa, Y. Kotake, M. Fujitani, H. Shintani, Y. Makino, and S. Ohta Regional distribution of parkinsonism-preventing endogenous tetrahydroisoquinoline derivatives and an endogenous parkinsonism-preventing substance-synthesizing enzyme in monkey brain Neurosci. Lett. 276 1999 68 70